Comparative Effectiveness and Payer-Provider Coordination in Multiple Sclerosis: What Does Managed Care Need to Know?

A continuing medical education activity sponsored by NAMCP and AAMCN.

Optimizing Treatment Regimens, Switching and Sequencing in Multiple Sclerosis: Leveraging Data to Make Informed Decisions is a 3-part live webinar series that will provide attendees with the
latest information in the management of Multiple Sclerosis

This is Part 3 of the series focusing on what managed care needs to know about Multiple Sclerosis

This activity is an archive from the webinar held December 18, 2019

This activity is valid from January 1, 2020 to January 1, 2022

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by educational grants from
Biogen and Genzyme Corporation

Description:
Multiple Sclerosis (MS) is a chronic progressive disease. It is the most common neurological cause of disability among young adults, with a prevalence of approximately 400,000 cases throughout the US, and every week around 200 people are diagnosed with the disease. Although there is still no cure for MS, many advances in MS treatment have arrived in recent years, allowing patients to manage these symptoms and improve their quality of life. While the explosion of these therapies have shown the ability to improve outcomes and quality of life in patient's MS, it makes staying current with best practices a challenge. This webinar series will allow attendees to be aware of the current treatment landscape as well as the cost implications to best develop a benefits design strategy and treatment plans that can minimize the economic burden and optimize care.

Upon completion of this activity, participants will be able to:

  • Review the available health economics & outcomes research (HEOR) and real world phase IV data of MS treatments

  • Discuss recent insights into cost offsets associated with new and emerging MS therapies

  • Integrate utilization management and benefit design strategies for MS therapies to enhance clinical and economic outcomes for patients with MS

  • Identify co-productive payer-provider strategies to ensure appropriate and timely access to disease-modifying therapies for MS

  • Identify practices that managed care professionals can take to help improve outcomes, mitigate disease progression and ensure appropriate and timely access to disease-modifying therapies for MS
     

Faculty: Gary Owens, MD
President
Gary Owens Associates
 

Disclosure:

Gary Owens, MD has no relevant financial relationships to disclose. His presentation has been reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by educational grants from
Biogen and Genzyme Corporation

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue